Conversion of Note. This Note shall be convertible into shares (the “Conversion Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), on the terms and conditions set forth in this Section 4.
Appears in 22 contracts
Samples: 25% Senior Secured Convertible Promissory Note and Security Agreement (Kiromic Biopharma, Inc.), 25% Senior Secured Convertible Promissory Note and Security Agreement (Kiromic Biopharma, Inc.), 25% Senior Secured Convertible Promissory Note and Security Agreement (Kiromic Biopharma, Inc.)
Conversion of Note. This Note shall be convertible into shares (the “Conversion Shares”) of the Company’s common stock, par value Common Stock at a price of $0.001 1.00 per share (the “Common StockConversion Price”), on the terms and conditions set forth in this Section 4.as follows:
Appears in 8 contracts
Samples: Promissory Note Amendment (Apimeds Pharmaceuticals US, Inc.), Promissory Note Amendment (Apimeds Pharmaceuticals US, Inc.), Promissory Note Amendment (Apimeds Pharmaceuticals US, Inc.)
Conversion of Note. This Note shall be convertible into shares (the “Conversion Shares”) of the Company’s common stock, par value 's Common Stock at a price of $0.001 1.00 per share (the “Common StockConversion Price”), on the terms and conditions set forth in this Section 4.as follows:
Appears in 1 contract
Samples: Promissory Note Amendment (Apimeds Pharmaceuticals US, Inc.)
